Teva Recalls Ranitidine Tablets in UK

Teva recalled all unexpired batches of its 100mg and 150mg ranitidine effervescent tablets in the UK over fears of N-nitrosodimethylamine (NDMA) contamination.

NDMA contamination of ranitidine products is currently being investigated by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the FDA, EMA and other regulators.

The MHRA has asked companies to quarantine batches of medicines that may be affected by the contaminant. “Relevant companies” have also been asked to conduct risk assessments and test potentially impacted batches, the agency said.